Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in Pediatr Dermatol

Retrieve available abstracts of 51 articles:
HTML format



Single Articles


    November 2022
  1. ANAND P, Schneeweiss S, Mostaghimi A, Schneeweiss MC, et al
    Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
    Pediatr Dermatol. 2022 Nov 20. doi: 10.1111/pde.15172.
    PubMed     Abstract available


  2. RICCIARDO BM, Kessaris HL, Kumarasinghe P, Carapetis JR, et al
    The burden of atopic dermatitis and bacterial skin infections among urban-living Indigenous children and young people in high-income countries: A systematic review.
    Pediatr Dermatol. 2022 Nov 9. doi: 10.1111/pde.15153.
    PubMed     Abstract available


    October 2022
  3. LARIJANI M, Zarowin D, Wohlschlaeger A, Perman MJ, et al
    Atopic dermatitis-like graft-versus-host disease treated with dupilumab.
    Pediatr Dermatol. 2022 Oct 21. doi: 10.1111/pde.15146.
    PubMed     Abstract available


  4. CHEN HW, Limmer EE, Joseph AK, Kinser K, et al
    Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: A randomized, controlled, evaluator-blinded s
    Pediatr Dermatol. 2022 Oct 20. doi: 10.1111/pde.15148.
    PubMed     Abstract available


  5. LABIB A, Golpanian RS, Aickara D, Smith P, et al
    The effect of fatty acids, vitamins, and minerals on pediatric atopic dermatitis: A systematic review.
    Pediatr Dermatol. 2022 Oct 20. doi: 10.1111/pde.15143.
    PubMed     Abstract available


    September 2022
  6. MCPHERSON T, Cork MJ, Goodhead C, Michaelis LJ, et al
    A real-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents.
    Pediatr Dermatol. 2022 Sep 20. doi: 10.1111/pde.15134.
    PubMed     Abstract available


  7. ITURRIAGA C, Bustos MF, Le Roy C, Rodriguez R, et al
    Association between obesity and atopic dermatitis in children: A case-control study in a high obesity prevalence population.
    Pediatr Dermatol. 2022 Sep 1. doi: 10.1111/pde.15110.
    PubMed     Abstract available


  8. SHI JQ, Dong XS, Zhang LL, Liu ZH, et al
    Herpes simplex virus encephalitis in atopic dermatitis patients and responses to dupilumab: A real association or a chance occurrence?
    Pediatr Dermatol. 2022;39:848-849.
    PubMed    


  9. BEZIRGANOGLU H, Arik Yilmaz E, Sahiner UM, Soyer O, et al
    The common triggers of urticaria in children admitted to the pediatric emergency room.
    Pediatr Dermatol. 2022;39:695-701.
    PubMed     Abstract available


    August 2022
  10. ALEXOPOULOS A, Dakoutrou M, Nasi L, Thanopoulou I, et al
    A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermat
    Pediatr Dermatol. 2022 Aug 29. doi: 10.1111/pde.15117.
    PubMed     Abstract available


  11. ZHENG DX, Cwalina TB, Mulligan KM, Gallo Marin B, et al
    Delayed medical care due to transportation barriers among US children with atopic dermatitis.
    Pediatr Dermatol. 2022 Aug 25. doi: 10.1111/pde.15124.
    PubMed     Abstract available


  12. SCOLLAN ME, Garzon MC, Lauren CT
    State medicaid coverage of over-the-counter moisturizers: A cost-effective management strategy for atopic dermatitis?
    Pediatr Dermatol. 2022 Aug 12. doi: 10.1111/pde.15038.
    PubMed     Abstract available


    July 2022
  13. O'CONNOR C, Livingstone V, Hourihane JOB, Irvine AD, et al
    Parental atopy and risk of atopic dermatitis in the first two years of life in the BASELINE birth cohort study.
    Pediatr Dermatol. 2022 Jul 25. doi: 10.1111/pde.15090.
    PubMed     Abstract available


  14. NGUYEN SM, Lee M, Lin W, Ngo JV, et al
    Blisters in a 7-year-old girl with atopic dermatitis.
    Pediatr Dermatol. 2022 Jul 13. doi: 10.1111/pde.15039.
    PubMed    


  15. SIRIPIPATTANAMONGKOL N, Rattanasak S, Taiyaitieng C, Inthajak Y, et al
    Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing.
    Pediatr Dermatol. 2022;39:601-605.
    PubMed     Abstract available


  16. MARTINEZ-CABRIALES SA, Shear NH
    Comment on "Toxic epidermal necrolysis (TEN) after first dose of Pfizer (BNT162b2) vaccination and pharmacogenomic-based-point-care support: First case report in pediatric and review of literature".
    Pediatr Dermatol. 2022;39:671-672.
    PubMed    


    May 2022
  17. MAZZONI D, Lobo Y, Levitt D, Wheller L, et al
    Severe atopic dermatitis in a 21-month-old boy successfully treated with dupilumab.
    Pediatr Dermatol. 2022 May 16. doi: 10.1111/pde.14996.
    PubMed     Abstract available


  18. SARVER MM, Quow K, Prose NS
    Atopic dermatitis leading to failure to thrive: A case report.
    Pediatr Dermatol. 2022 May 16. doi: 10.1111/pde.14983.
    PubMed     Abstract available


  19. CROCE EA, Rathouz PJ, Lopes FCPS, Leszczynska M, et al
    Validation of remote atopic dermatitis severity assessment with the Eczema Area and Severity Ondex in children using caregiver-provided photos and videos.
    Pediatr Dermatol. 2022 May 6. doi: 10.1111/pde.15003.
    PubMed     Abstract available


  20. THOMPSON AM, Seivright J, Hsiao JL, Shi VY, et al
    Bibliometric analysis of the 50 most cited publications in atopic dermatitis.
    Pediatr Dermatol. 2022 May 5. doi: 10.1111/pde.15027.
    PubMed     Abstract available


  21. ALJUNDI N, Utz Petry S, Moossavi M, Daveluy S, et al
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms following nivolumab and ipilimumab in a pediatric patient with melanoma.
    Pediatr Dermatol. 2022;39:486-487.
    PubMed     Abstract available


  22. ZALADONIS CA, Safeer LZ, Smith D, Hafeez F, et al
    Intralesional corticosteroid injections to treat lip swelling associated with oral Crohn's disease in a child.
    Pediatr Dermatol. 2022;39:506-508.
    PubMed     Abstract available


  23. CARMONA-CRUZ SA, Duran-McKinster LC, Garcia-Romero MT
    Atypical purpura and other features associated with unfavorable outcomes of IgA vasculitis (Henoch-Schonlein purpura) in children: A retrospective study.
    Pediatr Dermatol. 2022;39:369-371.
    PubMed     Abstract available


    March 2022
  24. DUPUY E, Afifi L, Jonas SJ, Cheng CE, et al
    A Case of severe mosquito bite allergy complicated by fatal hemophagocytic lymphohistiocytosis.
    Pediatr Dermatol. 2022 Mar 23. doi: 10.1111/pde.14877.
    PubMed     Abstract available


  25. RAMIREZ-MARIN HA, Silverberg JI
    Differences between pediatric and adult atopic dermatitis.
    Pediatr Dermatol. 2022 Mar 16. doi: 10.1111/pde.14971.
    PubMed     Abstract available


  26. RAO M, Grove D, Haggstrom A
    A rare presentation of herpes simplex virus encephalitis occurring in a pediatric patient on dupilumab for atopic dermatitis.
    Pediatr Dermatol. 2022 Mar 3. doi: 10.1111/pde.14970.
    PubMed     Abstract available


  27. HAVELE SA, Khurana MC, McMahon P, Murthy AS, et al
    Safety of dupilumab in a 5-month-old infant with severe atopic dermatitis.
    Pediatr Dermatol. 2022;39:291-294.
    PubMed     Abstract available


  28. ZHONG LS, Huang BQ, Tang WT, Zhuo ZQ, et al
    Bullous impetigo-like irritant contact dermatitis caused by perfume.
    Pediatr Dermatol. 2022;39:320-321.
    PubMed     Abstract available


    February 2022
  29. JOSEPH AK, Chen HW, Hassan Youssef S, Limmer EE, et al
    Evaluating the impact of a community health worker (Promotora de Salud) program on attitudes and beliefs regarding atopic dermatitis among Spanish-speaking Latin-American caregivers.
    Pediatr Dermatol. 2022 Feb 17. doi: 10.1111/pde.14917.
    PubMed     Abstract available


  30. CUNNINGHAM EP, Carter NF
    Tinea incognito "mask"erading as allergic contact dermatitis due to COVID-19 facial covering in children.
    Pediatr Dermatol. 2022 Feb 4. doi: 10.1111/pde.14911.
    PubMed     Abstract available


    January 2022
  31. PALLER AS, Beck LA, Blauvelt A, Siegfried EC, et al
    Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
    Pediatr Dermatol. 2022 Jan 26. doi: 10.1111/pde.14909.
    PubMed     Abstract available


  32. PARK HH, Haft MA, Burdick EA, Boiko S, et al
    Creating patient-directed education in pediatric dermatology: A guide for creators.
    Pediatr Dermatol. 2022;39:155-161.
    PubMed     Abstract available


  33. LEE EY, Wee CLP, Tan CH, Wee LWY, et al
    Pediatric patch testing in a multi-ethnic Asian population: A retrospective review.
    Pediatr Dermatol. 2022;39:69-76.
    PubMed     Abstract available


    December 2021
  34. ZHOU NY, Nili A, Blackwell CK, Ogbuefi N, et al
    Parent report of sleep health and attention regulation in a cross-sectional study of infants and preschool-aged children with atopic dermatitis.
    Pediatr Dermatol. 2021 Dec 21. doi: 10.1111/pde.14889.
    PubMed     Abstract available


    November 2021
  35. ASINIWASIS RN, Heck E, Amir Ali A, Ogunyemi B, et al
    Atopic dermatitis and skin infections are a poorly documented crisis in Canada's Indigenous pediatric population: It's time to start the conversation.
    Pediatr Dermatol. 2021;38 Suppl 2:188-189.
    PubMed     Abstract available



  36. Dupilumab for atopic dermatitis.
    Pediatr Dermatol. 2021;38:1559-1560.
    PubMed    


  37. GRAYSON C, Heath C
    Tips for addressing common conditions affecting pediatric and adolescent patients with skin of color.
    Pediatr Dermatol. 2021;38 Suppl 2:155-157.
    PubMed     Abstract available


    October 2021
  38. PARKER JJ, Sugarman JL, Silverberg NB, Gonzalez ME, et al
    Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children.
    Pediatr Dermatol. 2021 Oct 14. doi: 10.1111/pde.14820.
    PubMed     Abstract available


    September 2021
  39. ERTUGRUL A, Baskaya N, Cetin S, Bostanci I, et al
    Anaphylaxis and epinephrine autoinjector use in pediatric patients with cutaneous mastocytosis.
    Pediatr Dermatol. 2021 Sep 24. doi: 10.1111/pde.14800.
    PubMed     Abstract available


  40. BROOKS BE, Bercovitch L
    Closing the knowledge gaps in pediatric emergency department management of atopic dermatitis flares: Responding to the challenge.
    Pediatr Dermatol. 2021;38:1404-1405.
    PubMed    


  41. BERREBI D, Farmer W, Zinn Z
    BASCULE syndrome in a child with prior asymptomatic COVID-19 infection.
    Pediatr Dermatol. 2021;38:1342-1344.
    PubMed     Abstract available


  42. SHETH AP, Vivar KL, Wagner AM, Kruse LL, et al
    Henoch Schonlein purpura in pediatric patients with inflammatory bowel disease: A case series.
    Pediatr Dermatol. 2021;38:1389-1392.
    PubMed     Abstract available


  43. UGWU N, Cheraghlou S, Antaya RJ, Feng H, et al
    Trends in office visits and treatment for urticaria in children in the United States, 1998-2016.
    Pediatr Dermatol. 2021;38:1162-1168.
    PubMed     Abstract available


  44. JACKSON-COWAN L, Cole EF, Arbiser JL, Silverberg JI, et al
    TH2 sensitization in the skin-gut-brain axis: How early-life Th2-mediated inflammation may negatively perpetuate developmental and psychologic abnormalities.
    Pediatr Dermatol. 2021;38:1032-1039.
    PubMed     Abstract available


  45. MAHER MC, Hall EM, Horii KA
    Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
    Pediatr Dermatol. 2021;38:1370-1371.
    PubMed     Abstract available


  46. KING D, Roberts K, Stenton S, Jenkins A, et al
    Stevens-Johnson syndrome associated with Hodgkin's lymphoma.
    Pediatr Dermatol. 2021;38:1347-1348.
    PubMed     Abstract available


  47. EL HASBANI G, Taher AT, Jawad ASM, Uthman I, et al
    Henoch-Schonlein purpura: Another COVID-19 complication.
    Pediatr Dermatol. 2021;38:1359-1360.
    PubMed     Abstract available


  48. O'BRIAN M, Kolitz E, Jeong HS, Cao L, et al
    A severe presentation of acute generalized exanthematous pustulosis with non-infectious circulatory shock in an adolescent.
    Pediatr Dermatol. 2021;38:1267-1271.
    PubMed     Abstract available


  49. NAMBA T, Ebuchi Y, Manabe K, Shimizu J, et al
    Infantile leukocytoclastic vasculitis caused by enterotoxin-producing methicillin-sensitive Staphylococcus aureus.
    Pediatr Dermatol. 2021;38:1288-1291.
    PubMed     Abstract available


  50. KAPLAN F, Topal E
    Acute generalized exanthematous pustulosis due to Epstein-Barr virus infection in a neonate.
    Pediatr Dermatol. 2021;38:1354-1356.
    PubMed     Abstract available


  51. DAUGHERTY LN, Spraker MK, Lawley LP
    Neonate with migratory annular erythematous patches.
    Pediatr Dermatol. 2021;38:1320-1321.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: